| 产品详情 |
| Edit |   |
|---|
| Product Name | BH3I-1 |
|---|
| Description | BH3I-1 is a cell-permeable inhibitor that blocks the binding of BH3 peptides to Bcl-xL, inducing apoptosis. It inhibits interactions of BH3 domain-containing proteins with Bcl-xL, Bcl-2, and Bcl-W, inducing apoptosis in Bcl-2 or Bcl-W expressing cells with Ki values of 43.4 and 124 µM, respectively. BH3I-1 enhances radiation sensitivity in non-small cell lung cancer cells. MW: 400.31. Purity ≥97% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-[(4-bromophenyl)methylene]-a-(1-methylethyl)-4-oxo-2-thioxo-3-thiazolidineacetic acid |
|---|
| Gene, Accession, CAS # | CAS: 300817-68-9 |
|---|
| Catalog # | B1277-25 |
|---|
| Price | |
|---|
| Order / More Info | BH3I-1 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|